LoDoCo2 Low Dose Colchicine for secondary prevention in Stable Coronary Heart Disease (the LoDoCo2 Trial)

  • Thompson, Peter (Investigator 01)
  • Nidorf, Stefan (Investigator 02)
  • Eikelboom, John (Investigator 03)

Project Details

StatusFinished
Effective start/end date1/01/1531/12/20

Funding

  • National Health & Medical Research Council NHMRC: A$2,300,629.00